NO985671L - Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte - Google Patents

Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte

Info

Publication number
NO985671L
NO985671L NO985671A NO985671A NO985671L NO 985671 L NO985671 L NO 985671L NO 985671 A NO985671 A NO 985671A NO 985671 A NO985671 A NO 985671A NO 985671 L NO985671 L NO 985671L
Authority
NO
Norway
Prior art keywords
derivatives
diketone
substituted process
new thiazolidinedione
thiazolidinedione
Prior art date
Application number
NO985671A
Other languages
English (en)
Other versions
NO312100B1 (no
NO985671D0 (no
Inventor
Gurard Moinet
Gurard Botton
Etienne Prugnard
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO985671L publication Critical patent/NO985671L/no
Publication of NO985671D0 publication Critical patent/NO985671D0/no
Publication of NO312100B1 publication Critical patent/NO312100B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19985671A 1996-06-07 1998-12-04 Nytt tiazolidindion-2-derivat, fremgangsmåter for dets fremstilling, mellomproduktforbindelser, samt farmasöytiskepreparater som inneholder det NO312100B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607070A FR2749583B1 (fr) 1996-06-07 1996-06-07 Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
PCT/EP1997/002851 WO1997047612A1 (fr) 1996-06-07 1997-06-02 Nouveaux derives de thiazolidine-2,4-dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (3)

Publication Number Publication Date
NO985671L true NO985671L (no) 1998-12-04
NO985671D0 NO985671D0 (no) 1998-12-04
NO312100B1 NO312100B1 (no) 2002-03-18

Family

ID=9492815

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985671A NO312100B1 (no) 1996-06-07 1998-12-04 Nytt tiazolidindion-2-derivat, fremgangsmåter for dets fremstilling, mellomproduktforbindelser, samt farmasöytiskepreparater som inneholder det

Country Status (30)

Country Link
US (2) US6437143B2 (no)
EP (1) EP0918759B1 (no)
JP (2) JP3067809B2 (no)
KR (1) KR20000016412A (no)
CN (2) CN1075811C (no)
AR (1) AR008387A1 (no)
AT (1) ATE222897T1 (no)
AU (1) AU726549B2 (no)
BR (1) BR9709654A (no)
CA (1) CA2257275A1 (no)
CZ (1) CZ397598A3 (no)
DE (1) DE69715009T2 (no)
DK (1) DK0918759T3 (no)
EE (1) EE04015B1 (no)
ES (1) ES2180995T3 (no)
FR (1) FR2749583B1 (no)
HU (1) HUP0001744A3 (no)
ID (1) ID17810A (no)
IL (1) IL127408A (no)
NO (1) NO312100B1 (no)
NZ (1) NZ333645A (no)
PL (1) PL330363A1 (no)
PT (1) PT918759E (no)
RU (1) RU2169144C2 (no)
SK (1) SK164598A3 (no)
TR (1) TR199802518T2 (no)
TW (1) TW400330B (no)
UA (1) UA57024C2 (no)
WO (1) WO1997047612A1 (no)
ZA (1) ZA974984B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
NZ509172A (en) * 1998-09-21 2004-02-27 Univ Florida Antimalarial agents
CA2368146A1 (en) * 1999-03-18 2000-09-21 Ono Pharmaceutical Co., Ltd. A process for the preparation of thiazolidine derivatives
AU7073400A (en) 1999-08-27 2001-03-26 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
FR2822069B1 (fr) * 2001-03-19 2003-06-20 Lipha Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete
FR2826278B1 (fr) * 2001-06-20 2005-03-25 Lipha Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
US7411084B2 (en) 2001-09-26 2008-08-12 Emisphere Technologies, Inc. Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate
FR2838968A1 (fr) * 2002-04-30 2003-10-31 Lipha Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete
SE0201937D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab Therapeutic agents
FR2845003A1 (fr) * 2002-09-30 2004-04-02 Merck Sante Sas Utilisation de derives de thiazolidinedione comme inhibiteurs de l'aldose reductase
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US20060263453A1 (en) * 2004-11-01 2006-11-23 Thomas Smith Methods and compositions for modulating glutamate dehydrogenase
JP5202299B2 (ja) 2005-04-04 2013-06-05 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド デフェリチオシンポリエーテル類似体
AU2008229472B2 (en) 2007-03-15 2013-03-14 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
CN105250285B (zh) * 2007-04-11 2019-09-06 奥默罗斯公司 预防和治疗成瘾的组合物和方法
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
DE102007028925A1 (de) * 2007-06-22 2008-12-24 Saltigo Gmbh Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden
WO2013090750A1 (en) 2011-12-16 2013-06-20 University Of Florida Research Foundation, Inc. Uses of 4'-desferrithiocin analogs
US9815777B2 (en) 2013-09-22 2017-11-14 Jiva Pharma, Inc. Metformin salts to treat Type2 diabetes
JP6838966B2 (ja) 2013-11-22 2021-03-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． デスフェリチオシン類似体およびその使用
AU2016255770A1 (en) 2015-04-27 2017-11-16 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
SU1611216A3 (ru) * 1986-12-29 1990-11-30 Пфайзер Инк (Фирма) Способ получени производных тиазолидиндиона или их фармацевтически приемлемых солей с щелочными металлами
TW268952B (no) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
CA2195559A1 (en) * 1994-08-10 1996-02-22 Takashi Sohda Thiazolidinedione derivatives, their production and use

Also Published As

Publication number Publication date
AU3031797A (en) 1998-01-07
JP2000507270A (ja) 2000-06-13
HK1019601A1 (en) 2000-02-18
PL330363A1 (en) 1999-05-10
FR2749583A1 (fr) 1997-12-12
CN1221410A (zh) 1999-06-30
US20010007875A1 (en) 2001-07-12
CN1341588A (zh) 2002-03-27
ATE222897T1 (de) 2002-09-15
ID17810A (id) 1998-01-29
CA2257275A1 (en) 1997-12-18
FR2749583B1 (fr) 1998-08-21
ES2180995T3 (es) 2003-02-16
BR9709654A (pt) 1999-08-10
NO312100B1 (no) 2002-03-18
NZ333645A (en) 2000-05-26
CZ397598A3 (cs) 1999-03-17
IL127408A0 (en) 1999-10-28
EE04015B1 (et) 2003-04-15
US20030100587A1 (en) 2003-05-29
KR20000016412A (ko) 2000-03-25
SK164598A3 (en) 1999-06-11
CN1075811C (zh) 2001-12-05
DE69715009T2 (de) 2003-05-08
AR008387A1 (es) 2000-01-19
DK0918759T3 (da) 2002-11-25
WO1997047612A1 (fr) 1997-12-18
UA57024C2 (uk) 2003-06-16
JP2000226379A (ja) 2000-08-15
HUP0001744A3 (en) 2002-09-30
PT918759E (pt) 2003-01-31
HUP0001744A1 (hu) 2000-11-28
IL127408A (en) 2002-08-14
US6437143B2 (en) 2002-08-20
EE9800426A (et) 1999-06-15
AU726549B2 (en) 2000-11-09
JP3067809B2 (ja) 2000-07-24
TW400330B (en) 2000-08-01
DE69715009D1 (de) 2002-10-02
RU2169144C2 (ru) 2001-06-20
NO985671D0 (no) 1998-12-04
EP0918759B1 (fr) 2002-08-28
ZA974984B (en) 1997-12-30
EP0918759A1 (fr) 1999-06-02
TR199802518T2 (xx) 1999-04-21

Similar Documents

Publication Publication Date Title
NO985671L (no) Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte
DK0946512T3 (da) 6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
DE69716468D1 (de) 2-(purin-9-)-tetrahydrofuran-3,4-diol-derivate
NO983356D0 (no) Nye 19-nor-pregnenderivater
NO20011350L (no) 4-Karboksyaminosubstituerte 1,2,3,4-tetrahydrokinoliner som CETP inhibitorer
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO970174D0 (no) 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner
DK0885215T3 (da) Nye benzo-1,3-dioxolyl- og benzofuranyl-substituerede pyrrolidinderivater som endthelinantagonister
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DE59508591D1 (de) 2-arylcyclopentan-1,3-dion-derivate
DE59807073D1 (de) Substituierte 2-benzoyl-cyclohexan-1,3-dione
BR1100754A (pt) 4-alcóxi-2,6-di-t-butilfenol derivativos
FIU940050U0 (fi) Anordning foer maskinell torkning av organiskt loesmaterial, som straomaterial, torv, traeflis och motsvarande
FI963155A0 (fi) Diconelaserreaktor, Arringsstaelle med tryckturbin, Diconefusionsaccelerator (dubbelkon)
FI962118A0 (fi) Foerbaettrad anordning foer behandling av roekgaser, saerskilt avgaser
FI943502A0 (fi) Anordning foer koppling av arbetsmaskin till drivanordning, saosom traktor
ES1033065Y (es) Conjunto canula-tapa, perfeccionado.
DK0886645T3 (da) Nye 19-nor-pregnen-derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees